Blocking and Tackling - The Fundamentals of Stroke CT Interpretation

May 19, 2021
Non-contrast head CT remains the initial imaging modality in the workup of a patient with a suspected stroke, yet not everyone is comfortable with real time interpretation.
0 Comments

Challenges in Endovascular Therapy for Acute Stroke- What Should the Rest of Us Know?

May 11, 2021
Endovascular treatment of acute stroke is intimidating to many providers. Dr. Grossman takes this opportunity to share his expertise and help the rest of us understand what neurointervention can do for acute stroke patients and what the future of endovascular stroke care holds.
0 Comments

Difficult Strokes to Identify: Tricks and Tips From the Frontline

April 26, 2021
Identifying difficult stroke syndromes with Dr. Stacie Demel- learn from one of our nation's experts in stroke education and care as she takes us through the stroke syndromes that keep her up at night. The posterior circulation, the young patient, and the potential mimics that confuse us all are the focus of this podcast.
0 Comments

The New Standards for Prehospital Stroke Patient Destinations; the Dawn of a New Era in EMS

March 11, 2021
The destination for prehospital patients with suspected stroke has been controversial for many years. Should they be taken to the closest ED, the closest stroke ready hospital, or the closest comprehensive stroke center? Does rural, suburban, or urban location matter when selecting a receiving institution? The new AHA white paper addresses this and more.
0 Comments

IV tPA for Acute Strokes in Patients with COVID - What Does the Limited Evidence Mean?

December 4, 2020
The incidence of acute stroke in COVID-19 patients occurs at a rate that is at least 7 times greater than the general population. Controversy about the safety and efficacy of IV-tPA remains.
0 Comments
RSS
First123457910
Categories
More Entries

Nov 30

How do we implement ANNEXXa-I into our Clinical Practice?

Haemin Go posted on 11/30/2023


Moderator: W. Brian Gibler, MD, FACEP, FACC, FAHA
Other Participants: MD, Paul P. Dobesh, PharmD, FACC, FAHA, FCCP, BCPS, BCCP; Gregory J. Fermann, MD; Natalie Kreitzer, MD, MS

An anticoagulated patient presenting to the Emergency Department or Neurocritical Care Unit with intracranial hemorrhage (ICH) represents one of the most challenging clinical cases faced by emergency physicians and neurointensivists. Reversal of anticoagulation associated with treatment using Factor Xa inhibitors requires understanding the action of a specific agent, andexanet alfa. The ANNEXa-I trial, a randomized, controlled clinical trial for patients with ICH on anticoagulation, was stopped early before study completion in June 2024 due to efficacy of the andexanet alfa treatment arm versus usual care. In October 2023, a presentation at the 2023 World Stroke Conference provided further information on the trial results. In this Podcast, the faculty discusses the implications of ANNEXa-I for optimal management of ICH in the Emergency Department and Neurocritical Care Unit.


0 Comments
Please login or register to post comments.